Ajanta Pharma is currently trading at Rs. 982.20, up by 46.90 points or 5.01% from its previous closing of Rs. 935.30 on the BSE.
The scrip opened at Rs. 928.00 and has touched a high and low of Rs. 984.75 and Rs. 921.00 respectively. So far 63016 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 1019.95 on 02-Dec-2013 and a 52 week low of Rs. 326.67 on 25-Jan-2013.
Last one week high and low of the scrip stood at Rs. 984.75 and Rs. 925.05 respectively. The current market cap of the company is Rs. 3297.84 crore.
The promoters holding in the company stood at 73.60% while Institutions and Non-Institutions held 2.78% and 23.62% respectively.
Ajanta Pharma has reported results for third quarter ended December 31, 2013.
The company has reported 91.65% rise in its net profit at Rs 62.42 crore for the quarter as compared to Rs 32.57 crore for the same quarter in the previous year. Total income from operations of the company has increased by 31.18% at Rs 300.85 crore for quarter under review as compared to Rs 229.34 crore for the quarter ended December 31, 2012.
Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1854.15 |
Dr. Reddys Lab | 1350.75 |
Cipla | 1497.80 |
Lupin | 2357.65 |
Zydus Lifesciences | 1001.20 |
View more.. |